Indeed, methylation of genes such as MGMT, RAR-b, RASSF1A, p16INK4a, and DAPK have been reported in the serum DNA of lung cancer patients and can be considered as a tumor marker [73,74,75,76,77]. This evidence concerns the gene CDKN2A and lung carcinoma.